Skip to main content

Table 1 Clinical data

From: Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas

Patient

INSS

INRG

Age at diagnosis (months)

Follow up or outcome change (months)

Outcome

1p loss

MNA

11q loss

Origin

26R9

1

L

2

91

NED

neg

neg

neg

Adrenal gland

25R9

2

L

111

95

NED

neg

neg

neg

NA

20R9

2

L

3

113

NED

neg

neg

NA

NA

27R7

2

L

0

92

NED

neg

neg

neg

Intraspinal abdominal

33R7

2

L

3

92

NED

neg

neg

neg

NA

13E8

2

L

32

202

NED

neg

neg

neg

NA

15E7

3

L

0

0

DSC

neg

neg

neg

NA

15E3

3

L

12

195

NED

neg

neg

neg

NA

25R0

3

L

1

97

NED

neg

neg

neg

Thorax

13E6

3

L

48

12

DOD

pos

pos

pos

NA

11R4

3

L

15

27

DOD

pos

pos

neg

NA

10R8

3

L

80

59

DOD

neg

neg

pos

NA

9R9

3

L

24

21

DOD

pos

neg

pos

NA

10R2

4

M

15

12

DOD

pos

pos

neg

NA

15R3

4

M

28

9

DOD

pos

neg

pos

Adrenal gland

34R0

4

M

64

11

DOD

neg

neg

neg

Abdominal

17R2

4

M

80

45

DOD

neg

neg

pos

NA

26R8

4

M

21

18

DOD

pos

pos

NA

NA

28R8

4

M

29

26

DOD

neg

neg

pos

Adrenal gland

16E9

4

M

19

5

DOD

neg

pos

neg

NA

39R1

4

M

22

29

NED

pos

pos

neg

Abdominal

  1. Abbreviations: INSS, International neuroblastoma staging system; INRG, International neuroblastoma risk group; MNA, MYCN amplification; NA, Information not available; L, Localized; M, Metastasized; NED, No evidence of disease; DOD, Dead of disease; DSC, Dead by surgical complications; pos, Positive; neg, Negative.